Physician profile
John Lee
NPI 1255367108
$7,603.35
in general payments reported to CMS, 2019-2025
43 companies · $1,049 in 2025
The $1,049 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,971 · 2020: $370 · 2021: $1,330 · 2022: $1,083 · 2023: $948 · 2024: $852 · 2025: $1,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,848.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $923.62 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $922.78 | 2019-2025 | |
| Lilly USA, LLC | $885.56 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $684.28 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amarin Pharma, INC. | $546.89 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $392.03 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $361.26 | 2019-2024 | Synjardy, Jardiance |
| Amgen INC. | $308.42 | 2019-2025 | Evenity, Prolia |
| Pfizer INC. | $281.67 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $206.66 | 2019-2022 | |
| Abbott Laboratories | $185.67 | 2019-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $145.73 | 2019-2022 | |
| Antares Pharma, INC. | $145.26 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $141.40 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $135.67 | 2023 | Quviviq |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.